| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.196 | 17.399 | 23.413 | 23.051 | 27.338 | 24.293 | 34.251 | 46.046 | 58.163 | 60.244 |
| Total Income - EUR | 20.199 | 17.400 | 23.414 | 23.051 | 27.339 | 24.294 | 34.253 | 46.050 | 58.169 | 60.253 |
| Total Expenses - EUR | 24.910 | 28.432 | 33.297 | 32.177 | 34.615 | 32.453 | 33.119 | 36.849 | 39.298 | 44.579 |
| Gross Profit/Loss - EUR | -4.711 | -11.032 | -9.883 | -9.125 | -7.276 | -8.159 | 1.134 | 9.201 | 18.871 | 15.675 |
| Net Profit/Loss - EUR | -5.317 | -11.206 | -10.117 | -9.356 | -7.549 | -8.402 | 791 | 8.741 | 18.289 | 14.093 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Psymed - Gi S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.948 | 5.136 | 4.310 | 3.506 | 2.726 | 1.977 | 1.251 | 570 | 0 | 0 |
| Current Assets | 8.238 | 8.847 | 8.379 | 6.432 | 6.749 | 5.477 | 10.988 | 21.317 | 24.327 | 20.901 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.714 | 409 | 1.806 | 2.141 | 2.450 | 467 | 2.884 | 3.711 | 7.966 | 164 |
| Cash | 6.523 | 8.438 | 6.573 | 4.291 | 4.299 | 5.010 | 8.104 | 17.606 | 16.361 | 20.737 |
| Shareholders Funds | -20.667 | -31.662 | -41.243 | -49.842 | -56.427 | -63.759 | -61.554 | -53.004 | -34.554 | -20.268 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 34.852 | 45.645 | 53.933 | 59.780 | 65.902 | 71.213 | 73.792 | 74.891 | 58.880 | 41.169 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Psymed - Gi S.r.l.